What drove the recent move in 1332.HK stock?

The March 12 move was volume-driven. 1332.HK stock rose 51.20% to HKD 0.189 on **96.39M** shares, about 5.92 times average. That points to liquidity and repositioning rather than a single confirmed corporate news item.

How does Meyka AI view 1332.HK stock?

Meyka AI rates 1332.HK **60.29/100** (Grade B, HOLD). The score blends sector comparison, growth metrics, forecasts and analyst data. This is informational and not financial advice.

What are short-term price and risk scenarios for 1332.HK stock?

Short-term scenarios: momentum traders may chase above HKD 0.20 but expect volatility. Meyka’s monthly model target is HKD 0.13 (-31.22% vs HKD 0.189). Key risks include weak liquidity and negative EPS.

Where can I find official company details for Touyun Biotech?

Company filings and corporate information are on Touyun Biotech’s website [source](https://touyunbiotech.com.hk). Check regulatory announcements and the HKSE for official disclosures before trading.

HK Stocks

51.20% jump to HKD 0.189: Touyun Biotech (1332.HK, HKSE) high-volume mover, watch catalysts

ByDanny Kontos March 12, 2026

1332.HK stock jumped 51.20% to HKD 0.189 on March 12, 2026 as the HKSE session closed, driven by unusually high trading volume. Volume reached 96,388,125 shares versus a 50-day average of 16,287,810, roughly 5.92x average. The move put Touyun Biotech Group Limited (1332.HK) in our high-volume movers list for Hong Kong. Traders reacted intraday between HKD 0.130 and HKD 0.223, with a previous close of HKD 0.125. Below we break down drivers, valuation, technicals, Meyka AI grade and a model forecast to frame short-term trade and risk views.